Dirk Jäger
Heidelberg University · 425 works · 21,898 citations · h-index 63
Top works
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- 68 Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
- Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes
- Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
- Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study
- The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes
- Caring for patients with cancer in the COVID-19 era
- Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
- Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma
- Pan-cancer image-based detection of clinically actionable genetic alterations
- Optimizing the outcomes of pancreatic cancer surgery
- Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma
- Locally Advanced Pancreatic Cancer
- Improvement of surgical results for pancreatic cancer
- Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients
- Pancreatic Cancer Surgery
- CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
- Classification of current anticancer immunotherapies
- Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
- Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer